Literature DB >> 18695379

Regulation of coagulation by protein S.

Elisabetta Castoldi1, Tilman M Hackeng.   

Abstract

PURPOSE OF REVIEW: Protein S has been one of the least mechanistically understood amongst the vitamin K-dependent coagulation proteins, and diagnosis of protein S deficiency and quantification of the associated thrombotic risk are not straightforward. In this review, the regulation of thrombin generation by protein S and the pathophysiological implications of protein S deficiency are discussed in the light of recent findings on the anticoagulant function(s) of protein S. RECENT
FINDINGS: Protein S expresses both activated protein C-dependent and activated protein C-independent anticoagulant activities, but the former is generally believed to be lost upon binding of protein S to C4b-binding protein. Recently it has been shown that protein S acts as a cofactor of tissue factor pathway inhibitor in the down regulation of factor X-activation, which provides a mechanistic basis for the activated protein C-independent anticoagulant activity of protein S in plasma. In addition, reevaluation of the role of the protein S/C4b-binding protein complex has demonstrated that C4b-binding protein-bound protein S does express activated protein C-cofactor activity, especially during the inactivation of factor Va Leiden.
SUMMARY: These findings underscore the central role of protein S in the regulation of coagulation and may have important implications for the evaluation of the thrombotic risk associated with protein S deficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18695379     DOI: 10.1097/MOH.0b013e328309ec97

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  37 in total

1.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

2.  The Kunitz-3 domain of TFPI-alpha is required for protein S-dependent enhancement of factor Xa inhibition.

Authors:  Matthew Ndonwi; Elodee A Tuley; George J Broze
Journal:  Blood       Date:  2010-05-17       Impact factor: 22.113

3.  Generation and phenotypic analysis of protein S-deficient mice.

Authors:  François Saller; Anne C Brisset; Svetlana N Tchaikovski; Monica Azevedo; Roman Chrast; José A Fernández; Marc Schapira; Tilman M Hackeng; John H Griffin; Anne Angelillo-Scherrer
Journal:  Blood       Date:  2009-06-30       Impact factor: 22.113

Review 4.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

5.  C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies.

Authors:  Alfonso Buil; David-Alexandre Trégouët; Juan Carlos Souto; Noémie Saut; Marine Germain; Maxime Rotival; Laurence Tiret; Françcois Cambien; Mark Lathrop; Tanja Zeller; Marie-Christine Alessi; Santiago Rodriguez de Cordoba; Thomas Münzel; Philipp Wild; Jordi Fontcuberta; France Gagnon; Joseph Emmerich; Laura Almasy; Stefan Blankenberg; José-Manuel Soria; Pierre-Emmanuel Morange
Journal:  Blood       Date:  2010-03-08       Impact factor: 22.113

6.  Activated protein C light chain provides an extended binding surface for its anticoagulant cofactor, protein S.

Authors:  José A Fernández; Xiao Xu; Ranjeet K Sinha; Laurent O Mosnier; Michel F Sanner; John H Griffin
Journal:  Blood Adv       Date:  2017-08-07

7.  Similar hypercoagulable state and thrombosis risk in type I and type III protein S-deficient individuals from families with mixed type I/III protein S deficiency.

Authors:  Elisabetta Castoldi; Lisbeth F A Maurissen; Daniela Tormene; Luca Spiezia; Sabrina Gavasso; Claudia Radu; Tilman M Hackeng; Jan Rosing; Paolo Simioni
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

8.  Increased MerTK expression in circulating innate immune cells of patients with septic shock.

Authors:  Caroline Guignant; Fabienne Venet; Séverine Planel; Julie Demaret; Aurélie Gouel-Chéron; Christophe Nougier; Arnaud Friggeri; Bernard Allaouchiche; Alain Lepape; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2013-07-09       Impact factor: 17.440

9.  A Comprehensive Gene Expression Analysis of Resistance Formation upon Metronomic Cyclophosphamide Therapy.

Authors:  Rebekka Kubisch; Lilja Meissner; Stefan Krebs; Helmut Blum; Michael Günther; Andreas Roidl; Ernst Wagner
Journal:  Transl Oncol       Date:  2013-02-01       Impact factor: 4.243

10.  Protein S: a Multifunctional Anticoagulant.

Authors:  A'drianne Dorsey; Vijaya Satish Pilli; Howard Fried; Rinku Majumder
Journal:  Biomed Res Clin Pract       Date:  2017-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.